209 related articles for article (PubMed ID: 34716331)
21. Establishment of a novel cell line for the enhanced production of recombinant adeno-associated virus vectors for gene therapy.
Satkunanathan S; Wheeler J; Thorpe R; Zhao Y
Hum Gene Ther; 2014 Nov; 25(11):929-41. PubMed ID: 25072415
[TBL] [Abstract][Full Text] [Related]
22. Chromosomal latency and expression at map unit 96 of a wild-type plus adeno-associated virus (AAV)/Neo vector and identification of p81, a new AAV transcriptional promoter.
Hermonat PL; Santin AD; De Greve J; De Rijcke M; Bishop BM; Han L; Mane M; Kokorina N
J Hum Virol; 1999; 2(6):359-68. PubMed ID: 10774553
[TBL] [Abstract][Full Text] [Related]
23. Identification of the trans-acting Rep proteins of adeno-associated virus by antibodies to a synthetic oligopeptide.
Mendelson E; Trempe JP; Carter BJ
J Virol; 1986 Dec; 60(3):823-32. PubMed ID: 3023672
[TBL] [Abstract][Full Text] [Related]
24. Syntaxin 5-dependent retrograde transport to the trans-Golgi network is required for adeno-associated virus transduction.
Nonnenmacher ME; Cintrat JC; Gillet D; Weber T
J Virol; 2015 Feb; 89(3):1673-87. PubMed ID: 25410859
[TBL] [Abstract][Full Text] [Related]
25. Highly divergent integration profile of adeno-associated virus serotype 5 revealed by high-throughput sequencing.
Janovitz T; Oliveira T; Sadelain M; Falck-Pedersen E
J Virol; 2014 Mar; 88(5):2481-8. PubMed ID: 24335317
[TBL] [Abstract][Full Text] [Related]
26. Production of recombinant AAV vectors encoding insulin-like growth factor I is enhanced by interaction among AAV rep regulatory sequences.
Shi S; Mercer SA; Dilley R; Trippel SB
Virol J; 2009 Jan; 6():3. PubMed ID: 19128486
[TBL] [Abstract][Full Text] [Related]
27. Host determinants of adeno-associated viral vector entry.
Pillay S; Carette JE
Curr Opin Virol; 2017 Jun; 24():124-131. PubMed ID: 28672171
[TBL] [Abstract][Full Text] [Related]
28. High-titer adeno-associated viral vectors from a Rep/Cap cell line and hybrid shuttle virus.
Gao GP; Qu G; Faust LZ; Engdahl RK; Xiao W; Hughes JV; Zoltick PW; Wilson JM
Hum Gene Ther; 1998 Nov; 9(16):2353-62. PubMed ID: 9829534
[TBL] [Abstract][Full Text] [Related]
29. Inhibition of adenovirus cytotoxicity, replication, and E2a gene expression by adeno-associated virus.
Jing XJ; Kalman-Maltese V; Cao X; Yang Q; Trempe JP
Virology; 2001 Dec; 291(1):140-51. PubMed ID: 11878883
[TBL] [Abstract][Full Text] [Related]
30. Evidence for packaging of rep-cap sequences into adeno-associated virus (AAV) type 2 capsids in the absence of inverted terminal repeats: a model for generation of rep-positive AAV particles.
Nony P; Chadeuf G; Tessier J; Moullier P; Salvetti A
J Virol; 2003 Jan; 77(1):776-81. PubMed ID: 12477885
[TBL] [Abstract][Full Text] [Related]
31. Roles of adeno-associated virus Rep protein and human chromosome 19 in site-specific recombination.
Young SM; McCarty DM; Degtyareva N; Samulski RJ
J Virol; 2000 May; 74(9):3953-66. PubMed ID: 10756007
[TBL] [Abstract][Full Text] [Related]
32. Herpes simplex virus type 1 ICP0 protein mediates activation of adeno-associated virus type 2 rep gene expression from a latent integrated form.
Geoffroy MC; Epstein AL; Toublanc E; Moullier P; Salvetti A
J Virol; 2004 Oct; 78(20):10977-86. PubMed ID: 15452218
[TBL] [Abstract][Full Text] [Related]
33. Identification of the heparin binding site on adeno-associated virus serotype 3B (AAV-3B).
Lerch TF; Chapman MS
Virology; 2012 Feb; 423(1):6-13. PubMed ID: 22169623
[TBL] [Abstract][Full Text] [Related]
34. Impact of Medium-Sized Extracellular Vesicles on the Transduction Efficiency of Adeno-Associated Viruses in Neuronal and Primary Astrocyte Cell Cultures.
Kovács OT; Soltész-Katona E; Marton N; Baricza E; Hunyady L; Turu G; Nagy G
Int J Mol Sci; 2021 Apr; 22(8):. PubMed ID: 33921740
[TBL] [Abstract][Full Text] [Related]
35. A CRISPR Screen Identifies the Cell Polarity Determinant Crumbs 3 as an Adeno-associated Virus Restriction Factor in Hepatocytes.
Madigan VJ; Tyson TO; Yuziuk JA; Pillai M; Moller-Tank S; Asokan A
J Virol; 2019 Nov; 93(21):. PubMed ID: 31391273
[TBL] [Abstract][Full Text] [Related]
36. Second-strand synthesis is a rate-limiting step for efficient transduction by recombinant adeno-associated virus vectors.
Ferrari FK; Samulski T; Shenk T; Samulski RJ
J Virol; 1996 May; 70(5):3227-34. PubMed ID: 8627803
[TBL] [Abstract][Full Text] [Related]
37. OneBac: platform for scalable and high-titer production of adeno-associated virus serotype 1-12 vectors for gene therapy.
Mietzsch M; Grasse S; Zurawski C; Weger S; Bennett A; Agbandje-McKenna M; Muzyczka N; Zolotukhin S; Heilbronn R
Hum Gene Ther; 2014 Mar; 25(3):212-22. PubMed ID: 24299301
[TBL] [Abstract][Full Text] [Related]
38. DNA-binding activity of adeno-associated virus Rep is required for inverted terminal repeat-dependent complex formation with herpes simplex virus ICP8.
Alex M; Weger S; Mietzsch M; Slanina H; Cathomen T; Heilbronn R
J Virol; 2012 Mar; 86(5):2859-63. PubMed ID: 22205745
[TBL] [Abstract][Full Text] [Related]
39. EBV early lytic protein BFRF1 alters emerin distribution and post-translational modification.
Yadav S; Libotte F; Buono E; Valia S; Farina GA; Faggioni A; Farina A
Virus Res; 2017 Mar; 232():113-122. PubMed ID: 28238874
[TBL] [Abstract][Full Text] [Related]
40. Cross-dressing the virion: the transcapsidation of adeno-associated virus serotypes functionally defines subgroups.
Rabinowitz JE; Bowles DE; Faust SM; Ledford JG; Cunningham SE; Samulski RJ
J Virol; 2004 May; 78(9):4421-32. PubMed ID: 15078923
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
